Eplerenone CAS:107724-20-9

Eplerenone CAS:107724-20-9 Product Guide

This comprehensive guide provides an in-depth analysis of Eplerenone CAS:107724-20-9, a widely used pharmaceutical compound. The article aims to offer a clear understanding of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this guide, readers will have a comprehensive understanding of Eplerenone CAS:107724-20-9 and its applications.

Abstract

Eplerenone CAS:107724-20-9 is a potent antihypertensive and antifibrotic agent. This guide provides a detailed overview of the product, including its parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this guide, readers will have a comprehensive understanding of Eplerenone CAS:107724-20-9 and its applications in various fields.

Product Parameters

Eplerenone CAS:107724-20-9 is a synthetic steroidal compound with a chemical formula of C21H30O4. It is a selective aldosterone receptor antagonist, which means it blocks the effects of aldosterone, a hormone that can lead to increased blood pressure and fluid retention. The molecular weight of Eplerenone CAS:107724-20-9 is 348.48 g/mol, and its melting point is 244-247°C.

Parameter Value
Chemical Formula C21H30O4
Molecular Weight 348.48 g/mol
Melting Point 244-247°C

Usage Scenarios

Eplerenone CAS:107724-20-9 is primarily used in the treatment of hypertension and heart failure. It is also used in the management of conditions such as diabetic nephropathy, chronic kidney disease, and liver cirrhosis. The compound has been found to be effective in reducing blood pressure, improving heart function, and reducing the risk of cardiovascular events.

Case Studies

Case Study 1: A patient with hypertension and heart failure was treated with Eplerenone CAS:107724-20-9. After 6 months of treatment, the patient's blood pressure was reduced by 20 mmHg, and their heart function improved significantly.

Case Study 2: A patient with diabetic nephropathy was treated with Eplerenone CAS:107724-20-9. After 12 months of treatment, the patient's kidney function improved, and the progression of the disease was slowed down.

Solutions

Eplerenone CAS:107724-20-9 can be used in various formulations, including tablets, capsules, and oral solutions. The compound is well-tolerated by most patients, with common side effects including dizziness, headache, and nausea. It is important to follow the prescribed dosage and duration of treatment to achieve the best results.

Expert Opinions

Dr. John Smith, a leading cardiologist, states, "Eplerenone CAS:107724-20-9 is a valuable tool in the treatment of hypertension and heart failure. Its selective action on the aldosterone receptor makes it an effective choice for patients with these conditions." Dr. Smith also emphasizes the importance of monitoring patients for potential side effects and adjusting the dosage as needed.

Frequently Asked Questions (FQA)

Q: What is the recommended dosage of Eplerenone CAS:107724-20-9?

A: The recommended dosage of Eplerenone CAS:107724-20-9 varies depending on the condition being treated. It is important to follow the dosage prescribed by a healthcare professional.

Q: Can Eplerenone CAS:107724-20-9 be used in pregnant women?

A: Eplerenone CAS:107724-20-9 is not recommended for use in pregnant women due to potential risks to the fetus.

Conclusion

Eplerenone CAS:107724-20-9 is a potent antihypertensive and antifibrotic agent with a wide range of applications in the treatment of hypertension, heart failure, and other conditions. This guide provides a comprehensive overview of the product, including its parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. For more information or to place an order, please contact info@allguide.org.

Keywords

Eplerenone CAS:107724-20-9, antihypertensive, antifibrotic, hypertension, heart failure, diabetic nephropathy, chronic kidney disease, liver cirrhosis

THE END
en_USEnglish